NFKB1 and acute myeloid leukemia: This could also permit sustained ALDH1A1 gene expression: AML cells possess significant proteasome activity, which coincides with aggressive disease, and is the main mechanism of NFκB activation because it degrades the inhibitor IκB [50,51,52,53].